TCL Archive Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded April 10, 1998
TCL Archive Low Budget, Empty Beds, Lack Of Vision Beset Clinical Center, NIH Officials Say. June 20, 2008
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation September 27, 1985
